HIT Consultant December 9, 2024
Syed Hamza Sohail

What You Should Know:

– Cala Health, the non-invasive bioelectronic medicine leader, today announced it has raised a $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. 

– All existing Cala investors participated in the round, including Action Potential, Johnson & Johnson, Lightstone, Lux, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.

Cala Health: Revolutionizing Chronic Disease Care with Wearable Neuromodulation

Cala Health is a bioelectronic medicine pioneer transforming chronic disease care with wearable neuromodulation therapies. Combining neuroscience and advanced technology, the company delivers individualized peripheral nerve stimulation through its direct-to-home digital durable medical equipment (DME) platform, reshaping prescription therapy delivery. Founded in 2014 and headquartered in the San Francisco...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Related Articles:
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
B2B Wearables: A New Tool for Businesses to Promote Workplace Wellness
Q&A: Continuous health monitoring with wearables
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
Tozo S6 Affordable Smartwatch Suits Almost Any Lifestyle

Share This Article